Greenpass
Seed Round in 2024
Greenpass is a software-as-a-service (SaaS) platform focused on climate-resilient urban planning and design, aimed at creating livable cities. The platform provides tools for managing, optimizing, and certifying real estate assets to enhance their climate resilience and environmental impact. It supports urban development through nature-based solutions and green infrastructure while ensuring compliance with environmental, social, and governance (ESG) regulations. By addressing challenges such as climate change and urban heat islands, Greenpass enables stakeholders to maximize return on investment and value across both individual properties and entire portfolios.
CALYXHA Biotechnologies GmbH
Seed Round in 2020
CALYXHA Biotechnologies GmbH is a biotechnology company founded in 2019 and based in Vienna, Austria. The company focuses on developing innovative therapies aimed at addressing tissue degeneration, which is a primary underlying factor in numerous significant human diseases. Through its research and development efforts, CALYXHA seeks to provide effective solutions to improve health outcomes related to these conditions.
Eveliqure Biotechnologies
Series A in 2019
EveliQure Biotechnologies GmbH, founded in 2012 and headquartered in Vienna, Austria, focuses on developing a combined vaccine aimed at preventing diarrheal diseases caused by Shigella and ETEC bacteria. This innovative vaccine is the first of its kind to offer protection against both bacterial strains simultaneously, addressing a significant gap in previous vaccine development efforts that typically targeted only one strain. The vaccine employs a live attenuated strain of Shigella, engineered to provide broad protection against various species and serotypes of the pathogen. This advancement is particularly beneficial for travelers and individuals living in middle-income countries where these infections are prevalent, helping to enhance public health outcomes in affected regions.
Moonvision
Series A in 2019
MoonVision GmbH, founded in August 2017 and based in Vienna, Austria, specializes in utilizing artificial intelligence to analyze visual information for quality control and assurance. The company has developed a proprietary inspection system that employs advanced computer vision algorithms to detect item types and quantities, facilitating various operational improvements such as machine optimization and payment processes. MoonVision's technology enhances process reliability and offers detailed reporting, enabling manufacturers to automate and better understand their quality assurance processes. The company gained recognition by winning the "Startup of the Year" award in 2017 and was nominated for the "Go Silicon Valley Program" in 2018, securing partnerships with notable organizations such as Audi and A1.
Crystalsol
Venture Round in 2016
Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 in Estonia and later established in Vienna, Austria, Crystalsol's unique approach involves a flexible photovoltaic technology that utilizes a light-absorbing layer made of crystalline semiconductor particles, specifically copper, zinc, tin, sulfur, and selenium. This patented technology enables the production of high-efficiency solar cells through a roll-to-roll manufacturing process, significantly reducing capital requirements and minimizing common upscaling issues associated with thin film technologies. Crystalsol offers both transparent and opaque photovoltaic modules, designed for seamless integration into building structures such as windows, facades, and rooftops, thereby enhancing the stability and aesthetic appeal of solar energy solutions.
Airborne Robotics
Venture Round in 2016
Airborne Robotics GmbH, founded in 2005 and headquartered in Klagenfurt am Wörthersee, Austria, specializes in the design and manufacture of flying robots and drones tailored for industrial, agricultural, cinematic, and photographic applications. The company provides a complete package with its drones, such as the AIR6 and AIR8, which includes essential software and flight training, allowing customers to begin operations immediately upon delivery. These drones support a wide range of cameras and sensors, including thermal imaging and environmental analysis tools, making them adaptable for various tasks. Furthermore, Airborne Robotics promotes an open platform for developers, enabling specialists from diverse fields to customize and program their flying robots for specific functions, as the interfaces and software are readily accessible. The company's products are distributed globally, serving a broad customer base.
IDENTEC SOLUTIONS
Venture Round in 2016
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
AFFiRiS
Venture Round in 2016
AFFiRiS AG is a Vienna-based company specializing in the development and manufacture of peptide-based vaccines aimed at treating chronic diseases that have significant unmet medical needs. Established in 2003, the company's portfolio includes vaccines targeting a range of conditions such as Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. By focusing on tailored therapeutic solutions, AFFiRiS aims to address critical health challenges through innovative vaccine technology.
Crystalsol
Venture Round in 2015
Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 in Estonia and later established in Vienna, Austria, Crystalsol's unique approach involves a flexible photovoltaic technology that utilizes a light-absorbing layer made of crystalline semiconductor particles, specifically copper, zinc, tin, sulfur, and selenium. This patented technology enables the production of high-efficiency solar cells through a roll-to-roll manufacturing process, significantly reducing capital requirements and minimizing common upscaling issues associated with thin film technologies. Crystalsol offers both transparent and opaque photovoltaic modules, designed for seamless integration into building structures such as windows, facades, and rooftops, thereby enhancing the stability and aesthetic appeal of solar energy solutions.
Biocrates Life Sciences
Venture Round in 2015
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
CONDA Crowdinvesting Österreich
Venture Round in 2015
CONDA is the Austrian Crowd Investing platform for corporate investments and corporate finance.
Panoptes Pharma
Seed Round in 2015
Panoptes Pharma is a private biotechnology company based in Vienna, Austria, dedicated to developing small molecule therapies for severe eye diseases that currently lack effective treatments. The company's lead clinical candidate, PP-001, targets autoimmune uveitis, a significant cause of blindness, while also pursuing treatment for adenoviral conjunctivitis, which has no available therapies. With its innovative approach, PP-001 holds promise for addressing additional inflammatory and viral conditions. Panoptes Pharma is supported by a skilled team of development professionals with a successful history in bringing innovative products to market, focusing on a targeted portfolio of high-performance therapies to meet the pressing needs of patients suffering from serious eye disorders.
Nabriva Therapeutics
Venture Round in 2014
Nabriva Therapeutics plc is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to address serious infections. The company's lead product candidate, XENLETA, is the first systemic pleuromutilin antibiotic approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia. In addition to XENLETA, Nabriva is developing CONTEPO, a potential first-in-class epoxide antibiotic aimed at treating complicated urinary tract infections, including acute pyelonephritis. The company is also involved in clinical trials for other indications, including pediatric infections and sexually transmitted infections. Founded in 2005 and headquartered in Dublin, Ireland, Nabriva was previously known as Nabriva Therapeutics Forschungs GmbH before rebranding in 2007.
CONDA Crowdinvesting Österreich
Venture Round in 2014
CONDA is the Austrian Crowd Investing platform for corporate investments and corporate finance.
Crystalsol
Venture Round in 2014
Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 in Estonia and later established in Vienna, Austria, Crystalsol's unique approach involves a flexible photovoltaic technology that utilizes a light-absorbing layer made of crystalline semiconductor particles, specifically copper, zinc, tin, sulfur, and selenium. This patented technology enables the production of high-efficiency solar cells through a roll-to-roll manufacturing process, significantly reducing capital requirements and minimizing common upscaling issues associated with thin film technologies. Crystalsol offers both transparent and opaque photovoltaic modules, designed for seamless integration into building structures such as windows, facades, and rooftops, thereby enhancing the stability and aesthetic appeal of solar energy solutions.
IDENTEC SOLUTIONS
Venture Round in 2014
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
IDENTEC SOLUTIONS
Venture Round in 2013
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
Crystalsol
Venture Round in 2013
Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 in Estonia and later established in Vienna, Austria, Crystalsol's unique approach involves a flexible photovoltaic technology that utilizes a light-absorbing layer made of crystalline semiconductor particles, specifically copper, zinc, tin, sulfur, and selenium. This patented technology enables the production of high-efficiency solar cells through a roll-to-roll manufacturing process, significantly reducing capital requirements and minimizing common upscaling issues associated with thin film technologies. Crystalsol offers both transparent and opaque photovoltaic modules, designed for seamless integration into building structures such as windows, facades, and rooftops, thereby enhancing the stability and aesthetic appeal of solar energy solutions.
Mechatronic Systemtechnik
Venture Round in 2013
Mechatronic Systemtechnik GmbH, founded in 1998 and headquartered in Villach, Austria, specializes in the development and manufacturing of advanced equipment for the semiconductor processing industry. The company focuses on handling thin and warped wafers, offering a range of products including integrated OEM tools, stand-alone tools, loaders, wafer sorters, and ring removers. Additionally, Mechatronic Systemtechnik provides support and services to enhance automation in semiconductor manufacturing. With locations in Dresden, Germany, Penang, Malaysia, and Singapore, the company aims to improve production efficiency and yield for its clients through innovative solutions such as end effectors, pre-aligners, mapping systems, and advanced sensing technologies.
Marinomed
Venture Round in 2013
Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.
EUCODIS Bioscience
Convertible Note in 2013
EUCODIS Bioscience GmbH is a manufacturer of enzyme solutions that cater to various industries, including biopharma, fine chemicals, and cosmetics. Established in 2007 and based in Vienna, Austria, with a subsidiary in Germany, the company produces a diverse range of enzymes such as lipases, peroxidases, and nitrile hydratases. These enzymes facilitate applications including the stereospecific resolution of chiral alcohols and acids for active pharmaceutical ingredient synthesis, the production of sensitive esters, and the selective hydrolysis of fatty acids. Additionally, EUCODIS offers services in protein and enzyme engineering, bioprocess development, and industrial manufacturing. Their products are utilized by leading companies in the chemical, pharmaceutical, food, and cosmetics sectors to enhance production efficiency and comply with environmental standards.
Crystalsol
Series A in 2013
Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 in Estonia and later established in Vienna, Austria, Crystalsol's unique approach involves a flexible photovoltaic technology that utilizes a light-absorbing layer made of crystalline semiconductor particles, specifically copper, zinc, tin, sulfur, and selenium. This patented technology enables the production of high-efficiency solar cells through a roll-to-roll manufacturing process, significantly reducing capital requirements and minimizing common upscaling issues associated with thin film technologies. Crystalsol offers both transparent and opaque photovoltaic modules, designed for seamless integration into building structures such as windows, facades, and rooftops, thereby enhancing the stability and aesthetic appeal of solar energy solutions.
IDENTEC SOLUTIONS
Venture Round in 2012
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
Marinomed
Seed Round in 2012
Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.
Biocrates Life Sciences
Venture Round in 2012
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
Sail Labs Technology
Venture Round in 2012
Sail Labs Technology specializes in open-source intelligence systems that deliver actionable insights from various multimedia data sources, including television, radio, the internet, and social media. The company develops advanced technologies such as automatic speech recognition, speaker identification, named entity detection, and topic detection, which function across multiple languages and geographic regions. Its platform enables analysts and decision-makers to extract and analyze information from unstructured data, transforming it into meaningful intelligence. The product portfolio also features content-based search capabilities, visualization tools such as clustering and trend analysis, as well as workflow functionalities, profiles and ontologies, and a Social Media Extension, providing a comprehensive suite for enhanced data processing and decision-making.
IDENTEC SOLUTIONS
Venture Round in 2011
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
Marinomed
Venture Round in 2011
Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.
Crystalsol
Venture Round in 2011
Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 in Estonia and later established in Vienna, Austria, Crystalsol's unique approach involves a flexible photovoltaic technology that utilizes a light-absorbing layer made of crystalline semiconductor particles, specifically copper, zinc, tin, sulfur, and selenium. This patented technology enables the production of high-efficiency solar cells through a roll-to-roll manufacturing process, significantly reducing capital requirements and minimizing common upscaling issues associated with thin film technologies. Crystalsol offers both transparent and opaque photovoltaic modules, designed for seamless integration into building structures such as windows, facades, and rooftops, thereby enhancing the stability and aesthetic appeal of solar energy solutions.
Biocrates Life Sciences
Venture Round in 2011
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
Nabriva Therapeutics
Venture Round in 2011
Nabriva Therapeutics plc is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to address serious infections. The company's lead product candidate, XENLETA, is the first systemic pleuromutilin antibiotic approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia. In addition to XENLETA, Nabriva is developing CONTEPO, a potential first-in-class epoxide antibiotic aimed at treating complicated urinary tract infections, including acute pyelonephritis. The company is also involved in clinical trials for other indications, including pediatric infections and sexually transmitted infections. Founded in 2005 and headquartered in Dublin, Ireland, Nabriva was previously known as Nabriva Therapeutics Forschungs GmbH before rebranding in 2007.
Nabriva Therapeutics
Venture Round in 2010
Nabriva Therapeutics plc is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to address serious infections. The company's lead product candidate, XENLETA, is the first systemic pleuromutilin antibiotic approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia. In addition to XENLETA, Nabriva is developing CONTEPO, a potential first-in-class epoxide antibiotic aimed at treating complicated urinary tract infections, including acute pyelonephritis. The company is also involved in clinical trials for other indications, including pediatric infections and sexually transmitted infections. Founded in 2005 and headquartered in Dublin, Ireland, Nabriva was previously known as Nabriva Therapeutics Forschungs GmbH before rebranding in 2007.
IDENTEC SOLUTIONS
Venture Round in 2010
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
Biocrates Life Sciences
Venture Round in 2010
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
Biocrates Life Sciences
Venture Round in 2010
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
EUCODIS Bioscience
Series B in 2010
EUCODIS Bioscience GmbH is a manufacturer of enzyme solutions that cater to various industries, including biopharma, fine chemicals, and cosmetics. Established in 2007 and based in Vienna, Austria, with a subsidiary in Germany, the company produces a diverse range of enzymes such as lipases, peroxidases, and nitrile hydratases. These enzymes facilitate applications including the stereospecific resolution of chiral alcohols and acids for active pharmaceutical ingredient synthesis, the production of sensitive esters, and the selective hydrolysis of fatty acids. Additionally, EUCODIS offers services in protein and enzyme engineering, bioprocess development, and industrial manufacturing. Their products are utilized by leading companies in the chemical, pharmaceutical, food, and cosmetics sectors to enhance production efficiency and comply with environmental standards.
Mechatronic Systemtechnik
Venture Round in 2009
Mechatronic Systemtechnik GmbH, founded in 1998 and headquartered in Villach, Austria, specializes in the development and manufacturing of advanced equipment for the semiconductor processing industry. The company focuses on handling thin and warped wafers, offering a range of products including integrated OEM tools, stand-alone tools, loaders, wafer sorters, and ring removers. Additionally, Mechatronic Systemtechnik provides support and services to enhance automation in semiconductor manufacturing. With locations in Dresden, Germany, Penang, Malaysia, and Singapore, the company aims to improve production efficiency and yield for its clients through innovative solutions such as end effectors, pre-aligners, mapping systems, and advanced sensing technologies.
IDENTEC SOLUTIONS
Venture Round in 2009
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.
Biocrates Life Sciences
Venture Round in 2009
Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.
IDENTEC SOLUTIONS
Venture Round in 2008
Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.